#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 171

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Attention deficit hyperactivity disorder

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Guanfacine Hydrochloride and Atomoxetine Hydrochloride for Children and Adolescents with ADHD Aged 6 to 17 Years

Registered drug

Belgium

Participants:0–17 years
Substances:Guanfacine

Contact Research Centre

Netherton's syndrome

Not recruiting

Investigational

Study to Evaluate the Effectiveness of Spesolimab in Treating Patients with Netherton Syndrome

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Spesolimab

Contact Research Centre

High-grade B-cell lymphoma

Not recruiting

Registered drugNo placebo

Study on the Effect of DA-EPOCH-R and Nivolumab in Patients with Newly Diagnosed High-Grade B-Cell Lymphoma with MYC and BCL2/BCL6 Rearrangements

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Fallopian tube cancer+1

Not recruiting

Registered drugNo placebo

Study on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Study on the Effects of Atacicept in Adults with IgA Nephropathy

Not recruiting

Registered drug

Study on the Effects of Atacicept in Adults with IgA Nephropathy

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Atacicept

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing ARV-471 and Fulvestrant for Patients with Advanced Estrogen Receptor-Positive, HER2-Negative Breast Cancer After Endocrine Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Congenital generalised lipodystrophy

Not recruiting

Registered drugNo placebo

Study on Metreleptin for Children Under 6 with Generalized Lipodystrophy and Related Diabetes or High Triglycerides

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Metreleptin

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Registered drug

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide

Contact Research Centre

Myelofibrosis+2

Not recruiting

InvestigationalNo placebo

Continued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Itacitinib

Contact Research Centre

Dermatomyositis

Not recruiting

Investigational

Study on the Effects of GLPG3667 for Adults with Dermatomyositis

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Glpg3667 Fumarate

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.